ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

42
Analysis
Health CareIndia
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
bullishLaurus Labs
29 Oct 2024 00:42Broker

Laurus Labs - In-Line Quarter; CDMO Traction to Pick up in 2HFY25

Laurus Lab (LAURUS) delivered largely in-line operational performance for 2QFY25. It witnessed an improving traction in the CDMO business, with a...

Logo
181 Views
Share
bearishNTPC Ltd
26 Sep 2024 09:54

NIFTY Indices: Flows (Post Capping) At the Close Tomorrow; Round-Trip US$3.3bn

The next rebalance of the Nifty family of indices takes place at the close on 27 Sep. The round-trip trade is US$3.3bn and there are 13 stocks with...

Logo
436 Views
Share
10 Sep 2024 14:39

The US Biosecure Act: A Boon for Indian CDMO Players?

​The Biosecure Act passed by the U.S. House could boost Indian CDMOs as alternative to Chinese biotechs by 2032, leading to potential growth...

Logo
524 Views
Share
04 Sep 2024 11:30

SEBI's F&O Criteria Revision & Its Impact

​SEBI introduces stricter F&O eligibility criteria, impacting market liquidity and stability by including 80 stocks and excluding 18 to 23. #SEBI...

Logo
387 Views
Share
25 Aug 2024 12:00

NIFTY MIDCAP150 Index Rebalance: 19 Changes a Side; Lots of Overlap with Other Index Flow

There are 19 changes for the index in Sep. Estimated one-way turnover is 9.8% resulting in a one-way trade of INR 8.2bn (US$98m). There are many...

Logo
462 Views
Share
x